Repurposing human kinase inhibitors to create an antibiotic active against drug-resistant Staphylococcus aureus, persisters and biofilms.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Le, PhilippKunold, Elena
Macsics, Robert
Rox, Katharina
Jennings, Megan C
Ugur, Ilke
Reinecke, Maria
Chaves-Moreno, Diego
Hackl, Mathias W
Fetzer, Christian
Mandl, Franziska A M
Lehmann, Johannes
Korotkov, Vadim S
Hacker, Stephan M
Kuster, Bernhard
Antes, Iris
Pieper, Dietmar H
Rohde, Manfred
Wuest, William M
Medina, Eva

Sieber, Stephan A
Issue Date
2020-02Submitted date
2019
Metadata
Show full item recordJournal
Nature chemistryPubMed ID
31844194Type
ArticleLanguage
enEISSN
1755-4349ae974a485f413a2113503eed53cd6c53
10.1038/s41557-019-0378-7
Scopus Count
The following license files are associated with this item:
- Creative Commons
Related articles
- Synthetic cajaninstilbene acid derivatives eradicate methicillin-resistant Staphylococcus aureus persisters and biofilms.
- Authors: Yu JH, Xu XF, Hou W, Meng Y, Huang MY, Lin J, Chen WM
- Issue date: 2021 Nov 15
- Repurposing auranofin for the treatment of cutaneous staphylococcal infections.
- Authors: Thangamani S, Mohammad H, Abushahba MF, Sobreira TJ, Seleem MN
- Issue date: 2016 Mar
- Comparative Target Analysis of Chlorinated Biphenyl Antimicrobials Highlights MenG as a Molecular Target of Triclocarban.
- Authors: Macsics R, Hackl MW, Fetzer C, Mostert D, Bender J, Layer F, Sieber SA
- Issue date: 2020 Aug 3
- Identification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters Using a Fluorescence-Based Screening Strategy.
- Authors: Kim W, Conery AL, Rajamuthiah R, Fuchs BB, Ausubel FM, Mylonakis E
- Issue date: 2015
- Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
- Authors: Gatadi S, Gour J, Shukla M, Kaul G, Dasgupta A, Madhavi YV, Chopra S, Nanduri S
- Issue date: 2019 Aug 1